sep 29, 2020 - Regeneron’s monoclonal antibody treatment shows positive results in a Phase I/II/III trial. The cocktail is a mixture of 2 monoclonal antibodies: REGN10933 and REGN10987).
Added to timeline:
COVID 2020 - Policy, vaccines, therapies, and testing
Date:
